Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
QuantiPath is a digital pathology and artificial intelligence company that provides advanced image analysis solutions for clinical research and diagnostics. The company specializes in the quantitative assessment of tissue-based biomarkers, utilizing proprietary AI algorithms to enhance the precision and reproducibility of pathology data. QuantiPath's platform supports pharmaceutical and biotechnology companies in drug development, patient stratification, and the identification of novel spatial signatures in the tumor microenvironment. By automating complex manual workflows, the company aims to accelerate clinical trials and improve diagnostic accuracy in oncology and other therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on QuantiPath.